Resultados de longo prazo de estudo randomizado | Gefitinibe isolado vs. gefitinibe com quimioterapia para câncer de pulmão de não pequenas células com mutação no EGFR. 16 Ago, 2022 | 12:34h Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR – Journal of Clinical Oncology Estudo original: Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study – Journal of Clinical Oncology